We work with a number of different partners to identify and refine new quantitative reference standards, to establish proficiency testing schemes, and to ensure that HDx™ Reference Standards are available globally. Such partnerships are an important part of our mission to improve the quality and reliability of molecular testing.
Proficiency scheme organizers use our genetically defined, patient-relevant, Reference Standards to power their proficiency schemes.
The European Molecular Genetics Quality Network (EMQN) is a provider of External Quality Assessment (EQA) services which are essential for any laboratory seeking to maintain and provide a quality service.
UK NEQAS ICC (the UK National External Quality Assessment Service) is a leader in diagnostic proficiency assessment. They ensure optimal patient care by providing a comprehensive external quality assessment service in laboratory medicine.
The Canadian Immunohistochemistry Quality Control (cIQc) is an academic program based out of the Department of Pathology and Laboratory Medicine at the University of British Columbia in Vancouver, Canada. Committed to systematically monitoring and improving the proficiency of diagnostic pathology laboratories, the organization is the largest national external quality assurance program for immunohistochemical testing in Canada.
Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world.
PhenoPath PLLC is a physician-owned specialty pathology practice and reference laboratory providing diagnostic and contract research services to pathology and oncology practices, hospitals, biopharmaceutical companies and research institutions in the U.S., Canada and around the world.
Interested in working with us?